| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $355.9M | +539.7% |
| SG&A Expense | $66.2M | +388.5% |
| Operating Income | -$422.1M | -510.1% |
| Income Tax | $0 | — |
| Net Income | -$381.6M | -489.2% |
| EPS (Basic) | -$5.43 | +86.9% |
| EPS (Diluted) | -$5.43 | +86.9% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $218.1M | -18.3% |
| Current Assets | $736.6M | +133.1% |
| Total Assets | $742.7M | +132.1% |
| Current Liabilities | $85.2M | +435.6% |
| Total Liabilities | $86.4M | +229.7% |
| Stockholders' Equity | $656.3M | +738.1% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$169.7M | -175.9% |
| Capital Expenditures | $2.3M | — |
| Investing Cash Flow | -$447.7M | -835.3% |
| Financing Cash Flow | $568.4M | +107.3% |
| Free Cash Flow | -$172.0M | -179.6% |